CAM
BSX icon

Close Asset Management’s Boston Scientific BSX Stock Holding History

Close Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Sell
6,819
-400
-6% -$21.7K 0.01% 112
2026
Q1 		$453K Hold
7,219
– – 0.01% 105
2025
Q4 		$688K Hold
7,219
– – 0.02% 94
2025
Q3 		$705K Sell
7,219
-100
-1% -$10.4K 0.02% 92
2025
Q2 		$786K Hold
7,319
– – 0.02% 88
2025
Q1 		$738K Buy
7,319
+635
+10% +$63.9K 0.02% 87
2024
Q4 		$597K Hold
6,684
– – 0.02% 97
2024
Q3 		$560K Sell
6,684
-77
-1% -$6.07K 0.02% 98
2024
Q2 		$521K Sell
6,761
-1,330
-16% -$97.3K 0.02% 97
2024
Q1 		$554K Sell
8,091
-205
-2% -$13.2K 0.02% 93
2023
Q4 		$480K Buy
8,296
+671
+9% +$35.8K 0.02% 89
2023
Q3 		$403K Buy
7,625
+4,190
+122% +$220K 0.02% 90
2023
Q2 		$186K Buy
3,435
+2,065
+151% +$108K 0.01% 109
2023
Q1 		$69K Buy
+1,370
New +$64.6K ﹤0.01% 133

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Close Asset Management's BSX Position: Q2 2026 in Review

Close Asset Management reduced its Boston Scientific (BSX) stake by 5.5% in Q2 2026, selling an estimated $21.7K and leaving 6,819 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #112.

Close Asset Management first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $786K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Close Asset Management held 6,819 shares of Boston Scientific worth $291K as of Q2 2026.
  • Close Asset Management sold 400 Boston Scientific shares in Q2 2026, an estimated $21.7K.
  • Boston Scientific made up 0.01% of Close Asset Management's portfolio in Q2 2026, its #112 holding.
  • Close Asset Management first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Close Asset Management's Boston Scientific position peaked at $786K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.